| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |